Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity
Cureus · 06.05.2026
DOI: 10.7759/cureus.108385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 06.05.2026. Verfasst von Masuho Saburi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oita Prefectural Hospital, Oita, JPN. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Oita Prefectural Hospital, Oita, JPN.
- Hematology, Oita Kouseiren Tsurumi Hospital, Beppu, JPN.
- Hematology, National Hospital Organization Beppu Medical Center, Beppu, JPN.
- Hematology, Japan Community Health Care Organization (JCHO) Nankai Medical Center, Saiki, JPN.
Zitieren
APA
Saburi, M., Maehara, K., Nishikawa, T., Hiroyuki, T., Sakata, M., Kohno, K., Ogata, Y., Haruyama, T., & Ohtsuka, E. (2026). Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity. Cureus. https://doi.org/10.7759/cureus.108385
Vancouver
Saburi M, Maehara K, Nishikawa T, Hiroyuki T, Sakata M, Kohno K, et al. Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity. Cureus. 2026. doi:10.7759/cureus.108385
BibTeX
@article{Saburi2026,
author = {Saburi, Masuho and Maehara, Kuniaki and Nishikawa, Takumi and Hiroyuki, Takata and Sakata, Masanori and Kohno, Kazuhiro and Ogata, Yuko and Haruyama, Takami and Ohtsuka, Eiichi},
title = {Treatment Discontinuation of First-Line Bosutinib in a Real-World Cohort of Patients With Chronic Myeloid Leukemia: Impact of Hepatic Toxicity},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.108385}
}
EUVIMED